相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Post-COVID Interstitial Lung Disease-The Tip of the Iceberg
Namrata Kewalramani et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2023)
Pharmacological approaches to pulmonary fibrosis following COVID-19
Stefan Lassan et al.
FRONTIERS IN PHARMACOLOGY (2023)
Post-acute Sequelae of COVID-19 1 Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Sally J. Singh et al.
LANCET RESPIRATORY MEDICINE (2023)
Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post-COVID-19 Study
Iain Stewart et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK
Ivan Chun Hang Lam et al.
ECLINICALMEDICINE (2023)
Post-COVID-19 Pulmonary Fibrosis: Facts-Challenges and Futures: A Narrative Review
Duong-Quy Sy et al.
PULMONARY THERAPY (2023)
Chest CT Lung Abnormalities 1 Year after COVID-19: A Systematic Review and Meta-Analysis
Marialuisa Bocchino et al.
RADIOLOGY (2023)
Long-term Outcomes in Critical COVID-19 Survivors: A 2-Year Longitudinal Cohort
Jessica González et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2023)
Post COVID Interstitial Lung Abnormalities-Incidence and Management
Mark Robertshaw et al.
CURRENT PULMONOLOGY REPORTS (2023)
High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
Sahajal Dhooria et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Genetic overlap between idiopathic pulmonary fibrosis and COVID-19
Richard J. Allen et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis
Laura Fabbri et al.
THORAX (2022)
Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study
Gianna Vargas Centanaro et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Insights from Transcriptomics: CD1631 Profibrotic Lung Macrophages in COVID-19
Mallar Bhattacharya
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis
Richard J. Allen et al.
THORAX (2022)
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
Puja Mehta et al.
INTENSIVE CARE MEDICINE (2022)
Methylprednisolone in the treatment of post-COVID-19 Interstitial Lung Disease (STERCOV-ILD)
A. Yuksel et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Lung function and radiological findings 1 year after COVID-19: a prospective follow-up
Julia Tarraso et al.
RESPIRATORY RESEARCH (2022)
Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis
Jong Hyuk Lee et al.
RESPIRATORY RESEARCH (2022)
Follow-Up CT Patterns of Residual Lung Abnormalities in Severe COVID-19 Pneumonia Survivors: A Multicenter Retrospective Study
Giulia Besutti et al.
TOMOGRAPHY (2022)
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
Paola Faverio et al.
RESPIRATORY RESEARCH (2022)
Autopsy findings in COVID-19-related deaths: a literature review
Aniello Maiese et al.
FORENSIC SCIENCE MEDICINE AND PATHOLOGY (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Shorter telomere lengths in patients with severe COVID-19 disease
Raul Sanchez-Vazquez et al.
AGING-US (2021)
Healing after COVID-19: are survivors at risk for pulmonary fibrosis?
Lindsay T. McDonald
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
Daniel Wendisch et al.
CELL (2021)
Pathophysiology of the Acute Respiratory Distress Syndrome: Insights from Clinical Studies
Pratik Sinha et al.
CRITICAL CARE CLINICS (2021)
Genetic mechanisms of critical illness in COVID-19
Erola Pairo-Castineira et al.
NATURE (2021)
Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19
Peter A. Szabo et al.
IMMUNITY (2021)
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
Joao Fadista et al.
EBIOMEDICINE (2021)
Trends over Time of Lung Function and Radiological Abnormalities in COVID-19 Pneumonia: A Prospective, Observational, Cohort Study
Pierachille Santus et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Interstitial Lung Disease after COVID-19
Vincent Cottin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Rachael A. Evans et al.
LANCET RESPIRATORY MEDICINE (2021)
Correlation of autopsy pathological findings and imaging features from 9 fatal cases of COVID-19 pneumonia
Lingyun Zhao et al.
MEDICINE (2021)
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
Claire F. McGroder et al.
THORAX (2021)
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself
Marta Ferreira-Gomes et al.
NATURE COMMUNICATIONS (2021)
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Xiaojun Wu et al.
LANCET RESPIRATORY MEDICINE (2021)
Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service
Rebecca C. Robey et al.
ADVANCES IN THERAPY (2021)
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang et al.
LANCET (2021)
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Sandra Lopez-Leon et al.
SCIENTIFIC REPORTS (2021)
Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
Mei Zhou et al.
FRONTIERS IN MEDICINE (2021)
Persistent Post-COVID-19 Interstitial Lung Disease An Observational Study of Corticosteroid Treatment
Katherine Jane Myall et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures
Camilla Margaroli et al.
CELL REPORTS MEDICINE (2021)
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
Richard J. Allen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study
Andreina Manfredi et al.
INTERNAL MEDICINE JOURNAL (2020)
Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features
Jiong Wu et al.
INVESTIGATIVE RADIOLOGY (2020)
Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis
Pengfei Sun et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia
Jing Wu et al.
EUROPEAN RADIOLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George et al.
LANCET RESPIRATORY MEDICINE (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations
Mathilde Ducloyer et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2020)
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
Kacper Lechowicz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
Luca Carsana et al.
LANCET INFECTIOUS DISEASES (2020)
First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution
Maurizio Marvisi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Respiratory follow-up of patients with COVID-19 pneumonia
Peter M. George et al.
THORAX (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
Fibrotic Changes Depicted by Thin-Section CT in Patients With COVID-19 at the Early Recovery Stage: Preliminary Experience
Zhen Lu Yang et al.
FRONTIERS IN MEDICINE (2020)
Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study
Peixun Zhang et al.
BONE RESEARCH (2020)
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara et al.
RESPIRATORY RESEARCH (2018)
Unclassifiable interstitial lung disease: A review
Kate Skolnik et al.
RESPIROLOGY (2016)
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
Simon L. F. Walsh et al.
LANCET RESPIRATORY MEDICINE (2016)
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance
Ellen L. Burnham et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chest CT Features are Associated With Poorer Quality of Life in Acute Lung Injury Survivors
Ellen L. Burnham et al.
CRITICAL CARE MEDICINE (2013)
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Tasha E. Fingerlin et al.
NATURE GENETICS (2013)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Max A. Seibold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
DS Hui et al.
THORAX (2005)
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
RG Brower et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Medical progress - The acute respiratory distress syndrome.
LB Ware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)